Takeoff41 secures exclusive IP license from Stanford University

Takeoff41 obtained an exclusive license from Stanford University for the patent covering the core AI methods behind TPN2.0. The patent encompasses the data-driven approach to formulating standardized TPN compositions and assigning them to individual patients based on electronic health record data.

An exclusive license means Takeoff41 is the sole entity authorized to commercialize this technology.